In the December 2022 issue of Toxicological Sciences (ToxSci), the official journal of the Society of Toxicology (SOT), a Contemporary Review article examines the use of human-induced pluripotent stem cell–derived cardiomyocytes as a relevant assay for determining cardiac safety for regulatory purposes while a Forum article discusses a transformative vision for an ’omics-based regulatory chemical testing paradigm. Other featured publications include ToxSpotlight articles on the consequences of systematic methylmercury demethylation across development and on a new approach methodology–based assessment of the endocrine disruption potential of butylated hydroxytoluene.
Also, in the issue, the ToxSci Editor-in-Chief expresses appreciation for all the individuals who peer reviewed ToxSci articles in 2022, including the articles in the December issue:
ToxSci Volume 190, Issue #2, as well as all past issues, is available on the ToxSci website.
Remember that electronic access to ToxSci articles is a benefit for Full and Associate members—use your SOT credentials to log in and view ToxSci articles. Other membership types can request discounted access to ToxSci at any time.